Evan Lewis

Evan Lewis has a strong background in pharmaceutical development and analytical chemistry. Evan is currently working as the Executive Director of Pharmaceutical Development at Nurix Therapeutics since January 2023. Prior to this, they served as the Senior Director of Formulation Development at UNITY Biotechnology from July 2021 to January 2023. From February 2018 to July 2021, Evan held the position of Senior Director of Pharmaceutical Development at Kezar Life Sciences. Before that, they worked as an Independent Consultant, specializing in pharmaceutical development and analytical chemistry, from September 2015 to February 2018. Evan also gained extensive experience as the Director of Pharmaceutical Development at Calithera Biosciences from June 2010 to September 2015. Earlier in their career, they worked as a Principal Scientist at Proteolix from January 2004 to April 2010 and as a Scientist at Cytokinetics from 1999 to 2003 and at Coulter Pharmaceutical from 1998 to 1999.

Evan Lewis completed their PhD in Chemistry from the University of California, Santa Cruz between 1991 and 1996. Prior to this, no specific information is available about their education history at California State University-Sacramento.